Breast Cancer Survivors Push for Wider Insurance Coverage of Hair-Loss Prevention Treatments
By Dr. Natalie Singh
The Hidden Toll of Chemotherapy-Induced Hair Loss
For breast cancer survivors, the physical and emotional toll of chemotherapy is well-documented. Among the most distressing side effects is chemotherapy-induced alopecia—hair loss—that can profoundly impact self-esteem, mental health, and quality of life. Even as treatments like wigs and scarves provide support, many survivors are now advocating for broader access to scalp cooling systems, an evidence-based intervention proven to significantly reduce hair loss during chemotherapy.
How Scalp Cooling Works
Scalp cooling, also known as cold cap therapy, involves wearing a specialized cap or helmet during chemotherapy to constrict blood vessels in the scalp. This reduces the amount of chemotherapy drugs reaching hair follicles, thereby preserving hair growth. The U.S. Food and Drug Administration (FDA) has cleared several scalp cooling systems for this purpose, including the DigniCap Cooling System and others like the Amma Portable Scalp Cooling System currently under study at institutions such as the University of California, San Francisco (UCSF) and Dana-Farber Cancer Institute.
A 2026 review in Current Breast Cancer Reports confirms that scalp cooling is the only evidence-based method to prevent chemotherapy-induced alopecia, with success rates ranging from 50% to 90%, depending on the chemotherapy regimen and individual factors.
Why Insurance Coverage Remains a Barrier
Despite its proven efficacy, scalp cooling remains underutilized due to high out-of-pocket costs, often ranging from $500 to $2,000 per treatment session. Many insurance plans do not cover these devices, leaving survivors to bear the financial burden or forgo the treatment altogether.
New York State made history in January 2026 by becoming the first in the nation to mandate that large group private health insurers cover scalp cooling for chemotherapy patients. The law, signed by Governor Kathy Hochul in December 2024, reflects growing recognition of the psychosocial impact of hair loss and the importance of equitable access to hair-preservation options.
Advocacy Growing Nationwide
Breast cancer survivor Maureen Green shared her experience with scalp cooling, stating:
“When I was diagnosed, the thought of losing my hair was overwhelming. Scalp cooling gave me back a piece of my identity during treatment. Now, I’m advocating so no one else has to choose between their hair and their health.” Maureen Green, Breast Cancer Survivor
Green’s story is part of a broader movement pushing for national insurance coverage. Advocacy groups and medical professionals are urging policymakers to expand access, citing the long-term mental health benefits of preserving hair during cancer treatment.
What the Research Says
Recent clinical trials, including the COHAIR Study published in Breast (April 2026), compared the efficacy of scalp cooling systems versus chemical cooling caps. The study found that portable, FDA-cleared systems were more effective at preserving hair, with fewer complications such as scalp discomfort or frostbite.
a 2025 review in Current Treatment Options in Oncology highlighted that scalp cooling not only reduces hair loss but also improves patients’ quality of life and treatment adherence by mitigating the emotional distress associated with alopecia.
Key Takeaways for Patients and Providers
- Efficacy: Scalp cooling can significantly reduce or even prevent hair loss in up to 90% of cases, depending on the chemotherapy regimen.
- Cost: Without insurance coverage, costs can exceed $2,000 per treatment cycle. Advocacy efforts are increasing access in states like New York.
- Insurance Coverage: Always ask your provider about coverage options. Some plans may cover scalp cooling under experimental or investigational benefits.
- Clinical Trials: Patients interested in participating in ongoing trials, such as those at UCSF or Dana-Farber, can explore options through ClinicalTrials.gov.
The Future of Hair-Loss Prevention
As more states consider mandating insurance coverage and clinical trials expand, the goal is to make scalp cooling a standard of care for breast cancer patients undergoing chemotherapy. Survivors like Green, along with medical professionals, are leading the charge to ensure that no one has to sacrifice their hair—and their confidence—while fighting cancer.
References
- Scalp Cooling for Chemotherapy-Induced Alopecia in Breast Cancer: A Contemporary Review (2026)
- Cancer-Related Alopecia Risk and Treatment (2025)
- Efficacy of Scalp Cooling System vs. Chemical Cooling Cap (COHAIR Study, 2026)
- New York Mandates Insurance Coverage for Scalp Cooling (2026)
- ABC News: New York Law Gives Breast Cancer Patients a Chance to Keep Their Hair (2025)
- UCSF Clinical Trial: Portable Scalp Cooling System (2024-2025)